Professional
Added to YB: 2024-10-22
Pitch date: 2024-09-30
DHR [bullish]
Danaher Corporation
-18.27%
current return
Author Info
No bio for this author
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$162.8B
Pitch Price
$276.94
Price Target
N/A
Dividend
0.56%
EV/EBITDA
22.57
P/E
47.35
EV/Sales
7.39
Sector
Life Sciences Tools and Services
Category
growth
Baron Health Care Fund Added On Position: Danaher Corporation
DHR added to position: Market leader in bioprocessing for life sciences. Long-term growth in biologics demand. Post-COVID inventory destocking headwinds, but well-positioned for market recovery. Active stock buybacks signal management confidence. Attractive long-term prospects in growing biologic drug market.
Read full article (1 min)